News

Toronto Innovation Acceleration Partners Leads Investment in Northern Vascular Systems to Advance Clinical Development of Novel Light-Activated Embolization Technology TORONTO, ON — July 23, 2026 — Northern Vascular Systems (NVS),…

Canada has the science. Does it have the strategy to be a life sciences power? Co-authored by Matthew Carlyle, President and CEO, adMare BioInnovations; Prakash Gowd, Interim CEO, Toronto Innovation…

Synakis Announces Close of Oversubscribed Pre-Seed Round TORONTO, May 21, 2026 /CNW/ - Synakis Corp., a Toronto-based biotechnology company developing ocular therapies for retinal disease and glaucoma, announced today the close of…

TIAP is excited to have entered into a new partnership with Mission BioCapital to bring dedicated support from their Platinum Program to biotech start-ups here in Canada's leading health sciences…

TIAP Voices: Why Canadian Digital Health Companies Must Think Globally By: Mobeen Lalani, TIAP Manager, Technology and Venture Development Canadian digital health, artificial intelligence (AI), and medical device companies have long…

TIAP Launches Next Generation Program to Support Early-Stage Drug Development LAB150-NextGen to offer up to $1.6M USD per project to advance new drug candidatesMay 20, 2025Building on the success of…

TIAP Voices: The Venture Building Journey and the Importance of Balanced Investor Engagement by: Mobeen Lalani, TIAP Senior Analyst, Technology and Venture Development In today’s ever-evolving health innovation and business…

Government of Canada invests in southern Ontario’s life sciences sector From: Federal Economic Development Agency for Southern Ontario News release Six life sciences organizations expand manufacturing capabilities and commercialize innovations February…

Grey Matter Neurosciences Secures License for World-Leading Focused Ultrasound Technology from Sunnybrook Research Institute, Announces $14 Million Financing to Advance Treatment for Alzheimer's Disease News provided by Grey Matter Neurosciences …